Pain Medicine - SIMG supervisor agreement
Supervisors of Specialist International Medical Graduates (SIMG) assist ANZCA with the assessment process for SIMGs seeking eligibility for admission to fellowship.
Pain-experts-call-on-Minister-Hunt-to-review-17-Oct-2018
Chronic Pain MedsCheck trial submission_June 2022
Faculty of Pain Medicine (FPM) submission to the Medical Services Advisory Committee (MSAC) on the Pharmacy Guild of Australia’s Chronic Pain MedsCheck trial.
Working with the media
ANZCA has an experienced communications team that proactively engages with the media to highlight the important work of our anaesthetists and pain specialists. This includes sharing our latest evidence-based research and patient safety initiatives. We also actively encourage m...
Find out more
College publications
Our publications keep members up-to-date and lift the profile of anaesthesia and pain medicine with policy makers and in the wider community.
Find out more
College coat of arms
We were awarded letters patent for a coat of arms and crest in 1992. Letters patents are a published written order issued by a monarch granting an office, right, title or status to a person or corporation.
Find out more
$40 million Australian Government cut to chronic pain patients
Read our media release criticising the Australian Government for cutting $40 million from desperately needed services for people living
with chronic pain after it rejected key recommendations from a national taskforce.
CPD requirements for Rural Generalist Anaesthetists (RGAs)
In May 2023, the TC-RGA agreed that Rural Generalist Anaesthetists (RGAs) would be recommended to undertake the Continuing Professional Developement (CPD) program-level requirements identified in the ANZCA and FPM CPD standard.
Find out more
Australian impact of regional and global shortage of intravenous solutions
The Australian Therapeutic Goods Administration (TGA) have published an alert about a shortage of multiple intravenous (IV) fluid products in Australia due to global supply limitations, unexpected increases in demand, and manufacturing issues.
Find out more